A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients

NCT04004910 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

OTHER: Plasma soluble TNF receptor pulldown
OTHER: Plasma soluble TNF receptor pulldown + chemotherapy
DRUG: Chemotherapy Drugs, Cancer

Sponsor

Immunicom Inc